Pharmacology Cardiovascular drugs Part II

Slides:



Advertisements
Similar presentations
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 8 Cardiovascular.
Advertisements

Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 9 th Lecture.
Heart Failure Dr. Meg-angela Christi M. Amores. The term "cardiac failure" means simply failure of the heart to pump enough blood to satisfy the needs.
Cardiac drugs Cardiac glycoside Cardiac glycosides are the most effective drugs for treatment of C.H.F. Digitoxins are plant alkaloids. They increase myocardial.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Drugs Acting on the Renin-Angiotensin-Aldosterone System
By Lisa Bruno Gateway Community College April 1, 2011 Instructors Ellen Cummings, RN, MSN, CNE Beth Walker, RN, MSN, CNE.
CARDIOVASCULAR DISEASE 1.HYPERTENSION 2.ISCHAEMIC HEART DISEASE 3.THROMBO-EMBOLIC DISEASE Myocardial infarction Stroke Medical Pharmacolgy & Therapeutics.
Head Lines Etiology Risk factors Mechanism Complications Treatment.
CARDIOVASCULAR MODULE: HYPERTENSION Adult Medical-Surgical Nursing.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
1 Drug Treatment of heart failure. Prof. Azza El-Medani Prof. Abdulrahman Almotrefi.
CARBONIC ANHYDRASE INHIBITORS ACETAZOLAMIDE E It is a sulfonamide derivative. It is a sulfonamide derivative. noncompetitively but reversible inhibits.
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 25 Diuretics.
Complication during pregnancy and its nursing management: - Pregnancy induces hypertension. Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture.
1 Drug Therapy of heart failure. Prof. Azza El-Medani Prof. Abdulrahman Almotrefi.
Nursing and heart failure
MAINTAINING CARDIAC AND VASCULAR FUNCTION DR. IRENE ROCO ASST. PROFESSOR.
Drugs Affecting Blood Pressure Brenda B. Rowe. Vasopressors Treat shock Treat shock Dopamine (Intropin) – stimulates alpha-1 & beta-1 Dopamine (Intropin)
Bipyridines :(Amrinone,Milrinone ) only available in parenteral form. Half-life 3-6hrs. Excreted in urine.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
CARDIOVASCULAR DRUGS. Reference: Pharmacology in Rehabilitation 4th Edition Charles D. Ciccone, PT, PhD.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 46 Vasodilators.
Drugs Affecting the Cardiovascular System. Cardiovascular System Z Muscular organ with 4 chambers Z Pumps 5-6 liters blood/minute.
ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS. benazepril (Lotensin), Captopril (Capoten), enalapril (Vasotec), enalaprilat (Vasotec(IV), fosinopril (Monopril),
Source: Your Guide To Lowering Blood Pressure, Pathophysiology BMS 243 Hypertension Dr. Aya M. Serry 2015/2016.
Diuretics and Antihypertensives
 The ARBs include the following drugs:  azilsartan (Edarbi),candesartan (Atacand), eprosartan (Teveten), irbesartan(Avapro), losartan (Cozaar), olmesartan.
Internal Medicine Workshop Series Laos September /October 2009
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
Instructions for using this template.
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
Diuretics and Antihypertensives
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
Heart Failure  Dfinition:  Clinical features  Underlying causes of HF include Arteriosclerotic heart disease, MI, hypertensive heart disease, valvular.
Drugs for Hypertension
POTASSIUM-SPARING DIURETICS 1.Aldosterone antagonists: Spironolactone and eplerenone: The spironolactone-receptor complex is inactive complex results in.
CREATED BY Prof. Azza El-Medany
Drugs Used to Treat Heart Failure
Drugs for Lipid Disorders
Diuretics Thiazides are the preferred type of diuretic for treating hypertension, and all are equally effective in lowering blood pressure. In patients.
Drugs for Hypertension
Management of ST-Elevation Myocardial Infarction
Drugs Affecting the Cardiovascular System
Long Term Arterial Pressure Regulation & Hypertension
THE SILENT KILLER HYPERTENSION.
Heart Failure - Summary
Treatment of Congestive Heart Failure
Antihypertensive Drugs
Congestive heart failure
Circulatory disorders
Drugs Acting on the Renin-Angiotensin-Aldosterone System
Antianginal Drugs.
Anti hypertensive Drugs
Drugs Acting on the Heart
CARDIOVASCULAR AGENTS
Chapter 32 Assessment and Management of Patients With Hypertension
Drugs Affecting Blood Pressure
Chaper 20 Adrenoceptor Antagonists
Copyright Notice You are authorized to use these slides subject to the following terms, conditions and exceptions: They are to be used solely for personal,
Presentation transcript:

Pharmacology Cardiovascular drugs Part II

1. As a knowledgeable nurse, you know that the action of nitrates is: A. A. Smooth muscle contraction B. Vasoconstriction C. Smooth muscle relaxation D. Increase preload 1. Answer: C. Smooth muscle relaxation Nitrates cause smooth muscle relaxation, vasodilation, reduction of preload, and improved blood flow to the myocardium. Other choices have opposite effect of nitrates.

2. A 50-year-old client is prescribed to take nitrate each day for his condition. As a competent nurse, you know the result of nitrate administration is: A. Decreased myocardial oxygen demand B. Increased myocardial oxygen demand C. Increased left ventricular end-diastolic volume D. Increased atrial pressure 2. Answer: A. Decreased myocardial oxygen demand Nitrate administration will result in reduced preload and a decrease in myocardial oxygen demand and left ventricular end-diastolic volume.

3. A student nurse is asked to give an example of a long-acting nitrate. He is correct by saying: A. nitroglycerin sublingual B. nitroglycerin IV C. isosorbide PO D. nitroglycerin transmucosal 3. Answer: C. isosorbide PO Isosorbide is one of the most frequently administered long-acting nitrates. PO nitrates are longer acting than IV or SL agents.

4. When nitrates are administered early to the acute MI client, the effect is: A. Hypotension B. Bradycardia C. Reduced mortality D. Reduced morbidity 4. Answer: C. Reduced mortality Research has shown that when nitrates are administered early to the acute MI client, the effect is reduced mortality, infarct size, infarct extension, and related complications. Hypotension will result from nitrate administration, but it is not the reason for prescribing the drug. Tachycardia rather than bradycardia is more likely to occur with nitrate administration. The morbidity is already present because the client has the pain.

5. When teaching about nitrate administration, the nurse should instruct the client to: . A. Change position slowly. B. Take pulse daily. C. Reduce salt intake. D. Chew the sustained-release tablets 5. Answer: A. Change position slowly. Clients taking  nitrates should change position slowly to avoid orthostatic hypotension. It is not necessary to take the pulse before taking this drug. It is also not necessary to change the diet while taking this drug. It is contraindicated to chew sustained-release tablets.

6. ACEs participate in the renin-angiotensin-aldosterone system to have which of the following physiologic effects? A. Inhibit conversion of angiotensin II to angiotensin I B. Vasoconstriction and sodium depletion C. Promote sodium and water retention D. Stimulate vasodilation and inhibit sodium depletion 6. Answer: C. Promote sodium and water retention Angiotensin is a potent vasoconstrictor that stimulate the release of aldosterone. Aldosterone release promotes sodium and water retention. The conversion of angiotensin I to II is not inhibited. Aldosterone promotes sodium retention not depletion. Vasoconstriction not vasodilation results.

7. Nurse Margie just administered an ACE inhibitor to her client 7. Nurse Margie just administered an ACE inhibitor to her client. Before ambulating the client for the first time after administration, the nurse should monitor for: A. Hypokalemia B. Irregular heartbeat C. Edema D. Hypotension 7. Answer: D. Hypotension ACE inhibitors prevent vasoconstriction and lower blood pressure, placing the client at greater risk for postural (orthostatic) hypotension. ACE inhibitors reduce potassium excretion placing the client at risk for hyperkalemia. ACE inhibitors do not affect heart rate. ACE inhibitor promote sodium excretion thereby decreasing edema.

8. Mira is managing her hypertension with an ACE inhibitor 8. Mira is managing her hypertension with an ACE inhibitor. Which of the following statements stated by her indicates a need for further instruction? A. “I should not take my pills with food.” B. “I need to increase my intake of orange juice, bananas, and green vegetables.” C. “I will avoid coffee, tea, and colas.” D. “I will use salt substitutes that are not high in potassium.” 8. Answer: B. “I need to increase my intake of orange juice, bananas, and green vegetables.” The client needs to understand the risk of hyperkalemia and foods to eat in moderation. Taking medications with food will decrease therapeutic effects of ACE inhibitors. Excessive amounts of caffeine should be avoided. Avoidance of salt substitutes that are high in potassium decrease the risk of hyperkalemia.

9. Answer: D. “This drug is used when other drugs have failed.” 9. Pepito is a hypertensive client who has been placed on captopril (Capoten). He states, “Dr. del Mundo keeps changing my pills and none are working. I feel like a guinea pig.” Which of the following responses by the nurse would be most appropriate? A. “It often takes a while before the right medication is found.” B. “The doctor is just trying to help you control your blood pressure.” C. “The action of this drug is to work on both the arteries and to remove excess fluids.” D. “This drug is used when other drugs have failed.” 9. Answer: D. “This drug is used when other drugs have failed.” This response provides accurate information about the medication. Choice A placates the client and provides no information about the new medication. Choice B is defensive. Although choice C is true, there is no information provided to motivate the client.

10. The action of an ACE inhibitor interrupts the renin-angiotensin-aldosterone mechanism, thereby producing which of the following? A. Reduced renal blood flow B. Reduced sodium and water excretion C. Increased peripheral vascular resistance D. Increased sodium excretion and potassium reabsorption 10. Answer: D. Increased sodium excretion and potassium reabsorption The inhibition of aldosterone increases sodium excretion and reduces potassium excretion. ACE inhibitors increases renal blood flow. Excretion of sodium and water is enhanced by ACE inhibitors. Peripheral vascular resistance is decreased by vasodilation effect of ACE inhibitors.

11. Answer: A. Relax smooth muscles 11. Raymund is reviewing on cardiovascular drugs for his upcoming exam. For a well-prepared student, he should know that vasodilators are agents that: A. Relax smooth muscles B. Are used to treat hypotension C. Stimulate the adrenergic receptors of peripheral sympathetic nerves D. Cause respiratory depression 11. Answer: A. Relax smooth muscles Vasodilators relax smooth muscle. They are used to treat hypertension, not hypotension. Stimulating the adrenergic receptors of peripheral sympathetic nerves causes blood vessels to contract. Choice D is not an action of vasodilators.

12. As a competent nurse, you are aware that vasodilators are used mainly to treat: A. Diabetes B. Hypertension C. Atrial fibrillation D. Hypotension 12, Answer: B. Hypertension Vasodilators are used to treat hypertension. They are not used to treat diabetes. Atrial fibrillation is not treated with vasodilators. Vasodilators are not used to treat hypotension.

13. The drug/drugs used most commonly to treat peripheral or cerebral vascular obstructive disease is/are: A. pentoxifylline (Trental) B. cyclandelate (Cyclan) C. isoxsuprine (Vasodilan) D. All of the above 13. Answer: D. All of the above All are vasodilators used primarily to treat peripheral or cerebral vascular obstructive disease.

14. In a 50-year-old widower who had a transient ischemic attack, what is the most common vasodilator used for his treatment? A. norepinephrine B. dopamine (Intropin) C. papaverine (Pavabid) D. nitroprusside (Nitropress) 14. Answer: D. nitroprusside (Nitropress) Nitroprusside (Nitropress) is used in this situation. A and B are sympathomimetics used to treat hypotension. Papaverine is contraindicated in myocardial depressant states.

15. For a client taking drugs to treat peripheral vascular disease, it is important to provide health education about: A. Smoking cessation B. Developing a proper balance between rest and activity C. Proper foot care D. All of the above 15. Answer: D. All of the above An important component in the treatment of peripheral vascular disease is health education on preventing further injury to ischemic tissues. Medication therapy is only one aspect.

16. A clinical instructor asks a nursing student about aldosterone antagonist. The student is correct by saying that aldosterone antagonists: A. Create an osmotic gradient B. Inhibit the exchange of sodium for potassium C. Cause metabolic acidosis D. Work poorly in the presence of endogenous aldosterone 16. Answer: B. Inhibit the exchange of sodium for potassium Aldosterone antagonists compete with endogenous aldosterone and prevent sodium reabsorption in exchange for potassium elimination. Aldosterone antagonists work on inhibiting the action of aldosterone rather than creating an osmotic gradient. Aldosterone antagonist do not cause metabolic acidosis. Aldosterone antagonists must work in the presence of endogenous aldosterone.

A. Drowsiness B. Diarrhea C. Cystitis D. Hearing loss 17. Which of the following is a potential side effect of IV furosemide (Lasix)? A. Drowsiness B. Diarrhea C. Cystitis D. Hearing loss 17. Answer: D. Hearing loss Patients receiving large doses of loop diuretics are at risk for developing ototoxicity.

18. A 68-year-old client with a history of mild CHF and glaucoma is receiving IV mannitol (Osmitrol) to decrease intraocular pressure. The nurse would monitor the client for signs and symptoms of: A. Fluid volume excess B. Fluid volume deficit C. Hyperkalemia D. Hypernatremia 18. Answer: A. Fluid volume excess Mannitol’s osmotic effect extends to the bloodstream, where increased osmotic pressure draws fluid into the vascular space, thus elevating intravascular volume.

19. All potassium-sparing diuretics: A. Are required supplements during blood transfusion B. Enhance aldosterone action C. Cause hypokalemia D. Are weak diuretics 19. Answer: D. Are weak diuretics Potassium-sparing diuretics are not potent diuretics when used alone. They are used as adjunctive therapy with other diuretics to minimize potassium loss. Potassium-sparing diuretics given during blood transfusions tend to cause hyperkalemia because potassium is present in the transfusion. These drugs block aldosterone’s effects. These drugs cause hyperkalemia, not hypokalemia.

20. Which of the following clients is most likely to experience adverse effects from treatment with diuretics? A. A 21-year-old student B. A 40-year-old unmarried man C. A 60-year-old widower D. A 75-year-old man 20. Answer: D. A 75-year-old man Elderly clients are more sensitive to the effects of diuretics.

21. Kylie is reviewing drugs related to cardiovascular therapies 21. Kylie is reviewing drugs related to cardiovascular therapies. She should be aware that the desired action of lipid-lowering agents is to: A. Decrease HDL B. Increase TC C. Increase LDL D. Increase HDL 21. Answer: D. Increase HDL The desired effect of lipid-lowering agents is to decrease cardiac risk by lowering TC, TG, and LDL and increasing or maintaining HDL.

22. For lipid-lowering agents to be successful, drug therapy must lower: A. HDL B. LDL C. Total fat D. All of the above 22. Answer: B. LDL An elevated LDL is the most significant risk factor for the development of atherosclerosis; therefore, for drug therapy to be effective, LDL must be reduced.

23. As a competent nurse, you know that the most significant contraindication for therapy with lipid-lowering agent is: A. Renal disease B. Diabetes C. Liver disease D. Cardiac disease 23. Answer: C. Liver disease All lipid-lowering agents except the bile acid sequestrants are potentially hepatotoxic, so the most significant contraindication is liver disease.

24. Which of the following vitamins may not be absorbed properly when giving bile acid sequestrants? A. Vitamin B B. Vitamin C C. Vitamin B12 D. Vitamin K 24. Answer: D. Vitamin K Vitamin K absorption may be reduced when giving these drugs. The only fat-soluble vitamin here is vitamin K, which is synthesized in the liver.

25. Which of the following lipid-lowering agents has the common side effect of constipation? A. lovastatin (Mevacor) B. colestipol (Colestid) C. gemfibrozil (Lopid) D. niacin (Nicotinic acid) 25. Answer: A. lovastatin (Mevacor) Mevacor is known to cause constipation.

26. Parenteral anticoagulants work by disrupting: A. Conversion of prothrombin to thrombin B. Formation of thromboplastin C. Vitamin K-dependent clotting factors D. Conversion of prothrombin to fibrin 26. Answer: A. Conversion of prothrombin to thrombin Parenteral anticoagulants such as heparin work by disrupting conversion of prothrombin to thrombin. Tissue thromboplastin is formed in the extrinsic pathway as tissue is damaged. Oral anticoagulants work by interfering with vitamin K-dependent clotting factors. Prothrombin does not convert to fibrin.

27. SC heparin should be administered in the: A. Flank B. Abdominal fat C. Leg D. Gluteal area 27. Answer: B. Abdominal fat Heparin should be given in the abdominal area around the umbilicus, deep into the fat.

28. The half-life of heparin is: A. 10 minutes B. 1 to 1.5 hours C. 8 to 12 hours D. 1 to 2 days 28. Answer: B. 1 to 1.5 hours The half-life of heparin is 60 to 90 minutes. This is important to know when bleeding occurs during heparin administration.

29. Which drug is used to stop bleeding associated with heparin overdose? A. urokinase (Abbokinase) B. aminocaproic acid (Amicar) C. vitamin K (AquaMEPHYTON) D. protamine sulfate (Protamine) 29. Answer: D. protamine sulfate (Protamine) Protamine is the drug used to reverse the adverse effects of bleeding that occurs with heparin administration.

30. During warfarin (Coumadin) administration, the nurse can expect that the initial extension of PT occurs within _____ hours after therapy begins. A. 1 to 2 B. 4 to 6 C. 8 to 12 D. 12 to 24 30. Answer: C. 8 to 12 Initial extension of PT occurs within 8 to 12 hours after warfarin therapy begins.

16. A client

16. A client